American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1385)
  9. Gastrointestinal Oncology Service (1358)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (82)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (51)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (310)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (308)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8715)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (13)

More Publications

Results (9200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC)
    Meeting Abstract

    Seidman, A. D.; Brufsky, A.; Ansari, R. H.; Rubinsak, J. R.; Stein, R. S.; Schwartzberg, L. S.; Stewart, J. F.; Zhao, L.; Gill, J.; Tai, D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma
    Meeting Abstract

    Silberhumer, G.; Brader, P.; Wong, J.; Zamarin, D.; Serganova, I.; Blasberg, R.; Palese, P.; Fong, Y.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Beer, T. M.; Higano, C. S.; Tejwani, S.; Hamid, O.; Picus, J.; Harzstark, A.; Scher, H. I.; Lan, Z.; Lowy, I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adherence to extracolonic cancer screening in Lynch syndrome kindreds
    Meeting Abstract

    Stadler, Z. K.; Stern, R.; Devlin, V.; Glogowski, E.; Kauff, N.; Offit, K.; Hurley, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy
    Meeting Abstract

    Stephenson, A. J.; Klein, E. A.; Kattan, M. W.; Han, M.; Partin, A. W.; Walsh, P. C.; Trock, B. J.; Wood, D. P.; Eggener, S. E.; Eastham, J. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)
    Meeting Abstract

    Tew, W. P.; O'Cearbhaill, R.; Zhou, Q.; Thaler, H.; Konner, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Lichtman, S. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Characteristics of young women enrolled in a high-risk breast cancer screening program
    Meeting Abstract

    Tierney, S.; Delli Carpini, J. C.; Gemignani, M. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prostate Cancer Clinical Trials Consortium: A multicenter mechanism for the rapid design, development, and implementation of early phase clinical trials
    Meeting Abstract

    Vinson, J.; Mathew, P.; Beer, T. M.; Carducci, M. A.; Oh, W.; Small, E.; Wilding, G.; Higano, C.; Hussain, M.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Robertson, S.; Shen, A.; Wang, E.; Pace, L.; Dials, H.; Mendelson, D.; Shannon, P.; Gordon, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save